Nature’s Sunshine Products, Inc. (NASDAQ:NATR) Sees Significant Decrease in Short Interest

Nature’s Sunshine Products, Inc. (NASDAQ:NATR) saw a large decrease in short interest in November. As of November 30th, there was short interest totalling 87,200 shares, a decrease of 24.0% from the November 15th total of 114,800 shares. Currently, 0.6% of the company’s stock are sold short. Based on an average trading volume of 39,900 shares, the days-to-cover ratio is currently 2.2 days.

Nature’s Sunshine Products Trading Down 1.3 %

Shares of Nature’s Sunshine Products stock traded down $0.21 during trading on Friday, reaching $15.61. The company’s stock had a trading volume of 27,426 shares, compared to its average volume of 52,515. The stock has a 50-day moving average price of $14.68 and a two-hundred day moving average price of $14.56. The stock has a market capitalization of $288.47 million, a P/E ratio of 17.74 and a beta of 0.93. Nature’s Sunshine Products has a one year low of $10.81 and a one year high of $21.72.

Wall Street Analyst Weigh In

NATR has been the subject of a number of research reports. Canaccord Genuity Group began coverage on shares of Nature’s Sunshine Products in a report on Friday, September 13th. They issued a “buy” rating and a $18.00 price target for the company. StockNews.com raised Nature’s Sunshine Products from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, September 10th. Finally, Canaccord Genuity Group initiated coverage on Nature’s Sunshine Products in a research report on Friday, September 13th. They issued a “buy” rating and a $18.00 price objective for the company.

Insider Transactions at Nature’s Sunshine Products

In other Nature’s Sunshine Products news, major shareholder Fosun Pharmaceutical Shanghai sold 3,000 shares of the business’s stock in a transaction on Thursday, October 10th. The shares were sold at an average price of $13.39, for a total transaction of $40,170.00. Following the completion of the transaction, the insider now owns 69,347 shares of the company’s stock, valued at $928,556.33. The trade was a 4.15 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In the last quarter, insiders sold 7,499 shares of company stock worth $99,802. 4.70% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Nature’s Sunshine Products

A number of large investors have recently modified their holdings of the stock. XTX Topco Ltd bought a new stake in Nature’s Sunshine Products during the 2nd quarter worth about $180,000. Bailard Inc. acquired a new stake in Nature’s Sunshine Products during the 2nd quarter worth $197,000. Franklin Resources Inc. raised its position in shares of Nature’s Sunshine Products by 4.3% during the 3rd quarter. Franklin Resources Inc. now owns 20,744 shares of the company’s stock valued at $270,000 after acquiring an additional 856 shares during the last quarter. Barclays PLC lifted its stake in shares of Nature’s Sunshine Products by 51.8% in the 3rd quarter. Barclays PLC now owns 35,602 shares of the company’s stock valued at $485,000 after purchasing an additional 12,152 shares during the period. Finally, Bank of New York Mellon Corp boosted its position in shares of Nature’s Sunshine Products by 12.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 48,589 shares of the company’s stock worth $732,000 after purchasing an additional 5,425 shares during the last quarter. 79.40% of the stock is currently owned by institutional investors and hedge funds.

Nature’s Sunshine Products Company Profile

Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.